[HTML][HTML] Bench-to-bedside review: β2-Agonists and the acute respiratory distress syndrome

GD Perkins, DF McAuley, A Richter, DR Thickett, F Gao - Critical Care, 2003 - Springer
The acute respiratory distress syndrome (ARDS) is a devastating constellation of clinical,
radiological and pathological signs characterized by failure of gas exchange and refractory …

[HTML][HTML] The rise and fall of β-agonists in the treatment of ARDS

CR Bassford, DR Thickett, GD Perkins - Critical Care, 2012 - Springer
The acute respiratory distress syndrome (ARDS) is a severe inflammatory condition of the
lung, which can be triggered by a number of different pulmonary and extrapulmonary insults …

[HTML][HTML] Acute respiratory distress syndrome: pharmacological treatment options in development

RD Hite, PE Morris - Drugs, 2001 - Springer
The acute respiratory distress syndrome (ARDS) is a clinical syndrome with primarily
supportive management options. Despite extensive basic and clinical investigations …

Emerging drugs for acute lung injury

D Impellizzeri, G Bruschetta, E Esposito… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Acute respiratory distress syndromes (ARDS) are devastating disorders of
overwhelming pulmonary inflammation and hypoxemia, resulting in high morbidity and …

[HTML][HTML] Science review: Mechanisms of beta-receptor stimulation-induced improvement of acute lung injury and pulmonary edema

HE Groshaus, S Manocha, KR Walley, JA Russell - Critical care, 2004 - Springer
Acute lung injury (ALI) and the acute respiratory distress syndrome are complex syndromes
because both inflammatory and coagulation cascades cause lung injury. Transport of salt …

β2 agonist for the treatment of acute lung injury: a systematic review and meta-analysis

B Singh, AK Tiwari, K Singh, SK Singh, A Ahmed… - Respiratory …, 2014 - rc.rcjournal.com
BACKGROUND: The use of β2 agonist as an intervention for acute lung injury (ALI) and
ARDS patients is controversial, so we performed a systematic review and meta-analysis of …

Pharmacological therapy for acute respiratory distress syndrome

R Jain, A DalNogare - Mayo Clinic Proceedings, 2006 - Elsevier
Acute respiratory distress syndrome (ARDS) is an inflammatory process caused by a variety
of direct and indirect injuries to the lungs. Despite improvements in supportive care and …

Inhaled β2 adrenergic agonists and other cAMP-elevating agents: therapeutics for alveolar injury and acute respiratory disease syndrome?

K Sriram, MB Insel, PA Insel - Pharmacological Reviews, 2021 - ASPET
Inhaled long-acting β-adrenergic agonists (LABAs) and short-acting β-adrenergic agonists
are approved for the treatment of obstructive lung disease via actions mediated by β 2 …

Pharmacotherapy for acute respiratory distress syndrome

H Shafeeq, I Lat - … : The Journal of Human Pharmacology and …, 2012 - Wiley Online Library
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) represent a
continuum of a clinical syndrome of respiratory failure due to refractory hypoxia. Acute …

Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome

M Cepkova, MA Matthay - Journal of intensive care …, 2006 - journals.sagepub.com
Acute lung injury and the acute respiratory distress syndrome are common syndromes with a
high mortality rate that affect both medical and surgical patients. Better understanding of the …